SCHEMBL19744256

SCHEMBL19744256

COC(=O)/C=C(\Oc1ccc(Cl)cc1OC)C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
SLC6A2 P23975 4/20 0.42
SLC6A4 P31645 4/20 0.42
SLC6A3 Q01959 3/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 3/20 0.41
AMY1A P0DUB6 1/20 0.40
TTR P02766 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39
KCNMA1 Q12791 1/20 0.39
KCNH2 Q12809 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19744257 1.00 MEN1 (0.43) MEN1KMT2ACYP11B1CYP11B2PDE4A
SCHEMBL19744159 0.83 PDE4A (0.42) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL19743723 0.83 PDE4A (0.42) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL19744209 0.81 ATM (0.43) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL19744095 0.81 ATM (0.43) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL29986082 0.77 ALDH1A1 (0.45) MEN1KMT2ACYP11B1CYP11B2LMNA
SCHEMBL19744249 0.77 ALDH1A1 (0.45) MEN1KMT2ACYP11B1CYP11B2LMNA
SCHEMBL19744270 0.77 ALDH1A1 (0.45) MEN1KMT2ACYP11B1CYP11B2LMNA
SCHEMBL19744050 0.75 LMNA (0.44) MEN1KMT2APDE4APDE4BPDE4C
SCHEMBL21187112 0.75 LMNA (0.44) MEN1KMT2APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641864-B Anti-infective agents 邓迪大学 2023-04-04 CN disclosed
US-11485720-B2 Anti-infective agents UNIVERSITY OF DUNDEE (GB) 2022-11-01 US disclosed
EP-3472141-B1 ANTI-INFECTIVE AGENTS UNIV DUNDEE (GB) 2022-10-05 EP disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
EP-3472141-A1 ANTI-INFECTIVE AGENTS University Of Dundee (GB) 2019-04-24 EP disclosed
WO-2017221002-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485720-B2 Anti-infective agents C1R, RRS1, ARG1 MEN1 3356/4885KMT2A 3024/4885CYP11B1 2508/4885
US-20210101877-A1 ANTI-INFECTIVE AGENTS C1R, RRS1, ARG1 MEN1 3356/4885KMT2A 3024/4885CYP11B1 2508/4885
US-20190225592-A1 ANTI-INFECTIVE AGENTS C1R, ARG1, MSR1 MEN1 3517/4885KMT2A 3120/4885CYP11B1 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.